A Comment on dementia and Alzheimer's disease costs, in the context of SDG 3, focusing specifically on the costs of care in Europe.
Dementia is a syndrome characterized by progressive cognitive and functional impairment, most commonly caused by Alzheimer's disease and other neurodegenerative and cerebrovascular disorders. Costs of care increase dramatically with progressing disease severity, and increasing dementia prevalence due to ageing populations is raising concerns about the sustainability of future costs of dementia care. A new study shows that social welfare systems in Europe cover most of the direct costs of dementia, however they do not protect families and households against the burden of informal care. Meier and colleagues1 set out to calculate the economic costs of dementia in 11 European countries, by combining microdata from a population-based survey with estimates of dementia prevalence. Data for Austria, Belgium, Czechia, Denmark, Estonia, France, Germany, Italy, Slovenia, Spain, and Sweden was obtained from six waves of the Survey of Health, Ageing, and Retirement in Europe (SHARE). The survey captured out-of-pocket expenditures for health and social care as well as unpaid informal care. Costs attributable to dementia were estimated using linear regression, controlling for comorbidities and demographic factors. Finally, costs were combined with prevalence estimates to calculate the annual cost of dementia by country.
Climate action seems to be more popular among those who vote.
An Article in support of SDG 3, examining the treatment pathway for hip replacements over the life of the patient in terms of risk of revision and re-revisions.
This Article supports SDGs 3 and 10, assessing the effect of housing modifications of disability outcomes, with a particular focus on the ageing population.
Plant Extracts in Neurodegenerative Diseases, 2022, Pages 1-15
This book chapter advances SDG #3 and #10 by focusing on polyphenols and flavonoids and their crucial role in decreasing AD symptoms. In addition, it highlights the neuroprotective role of various essential ingredients of plant extracts such as Icariside, Onjisaponin B, Asarones, Liquiritin, Tanshinone IIA (TIIA) and cryptotanshinone (CT), Ginsenoside Rg1, and n-Butylidenephthalide. The efficacy of green nanotechnology are also discussed.
This Article supports SDG 3 by providing new insights on the degree and determinants of real-world PrEP effectiveness among men at risk of HIV in France, with relevance in the current context of worldwide PrEP scale up.
This systematic review aims to identify articles that systematically reviewed measures of ADL for children and adolescents aged 7–18 years with DD to evaluate the quality of included articles, and describe the measures and domains identified.
Background and aims: The risk prediction of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) is a challenge especially in the era of antiviral therapy. The aim of this meta-analysis was to comprehensively evaluate the performance of existing HCC prediction scores in HCC prediction on antivirals. Methods: We searched PubMed, Web of Science and Cochrane Library for relevant prospective studies from the inception to August 24, 2021.
An Article in support of SDGs 2, 13, and 15, assessing the environmental consequences and nutritional contributions of national food-based dietary guidelines while considering circular food system principles
An Editorial on the cost of living crisis, in the context of SDGs 1, 2, and 3, calling for governments to act urgently to address poverty and food insecurity to avoid further compromising the health of populations, especially children.
